[HTML][HTML] Inhibition of NF-κB signaling unveils novel strategies to overcome drug resistance in cancers
Y Li, B Zhao, J Peng, H Tang, S Wang, S Peng… - Drug Resistance …, 2024 - Elsevier
Drug resistance in cancer remains a major challenge in oncology, impeding the
effectiveness of various treatment modalities. The nuclear factor-kappa B (NF-κB) signaling …
effectiveness of various treatment modalities. The nuclear factor-kappa B (NF-κB) signaling …
Serine/threonine kinase 36 induced epithelial-mesenchymal transition promotes docetaxel resistance in prostate cancer
T He, NX Li, ZJ Pan, ZH Zou, JC Chen, SZ Yu, F Lv… - Scientific Reports, 2024 - nature.com
To investigate the role and potential mechanism of serine/threonine kinase 36 (STK36) in
docetaxel resistance-prostate cancer (PCa). The expression of STK36 in PCa and the …
docetaxel resistance-prostate cancer (PCa). The expression of STK36 in PCa and the …
Immunostimulatory bacteria for the treatment of cancer
JF Anker, P Thumbikat, SA Abdulkadir… - US Patent …, 2024 - Google Patents
CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1 [C@ H](C (C)
NC) CC [C@@ H](N)[C@ H] 1O [C@ H] 1 [C@ H](O)[C@@ H](O [C@@ H] 2 [C …
NC) CC [C@@ H](N)[C@ H] 1O [C@ H] 1 [C@ H](O)[C@@ H](O [C@@ H] 2 [C …